Q-linea AB (CHIX:QLINES) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:QLINES Q-linea AB CHIX:QLINES
64 GF Score
Price kr1,610.00
GF Value kr1,855.74
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Net Loan?

Net Loan only applies to banks and insurance companies.

CHIX:QLINES
64GF Score
Q-linea AB CHIX:QLINES
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Q-linea AB (CHIX:QLINES) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr1,610.00 is trading 13.2% below its estimated GF Value™ of kr1,855.74.

Key valuation signals for CHIX:QLINES:

  • Net Loan:
  • GF Value™: kr1,855.74 vs. price of kr1,610.00 (13.2% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the CHIX:QLINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
64GF Score

Get the complete analysis for CHIX:QLINES

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,610.00
Price
kr1,855.74
GF Value